AIM IMMUNOTECH INC. Debt Securities, Available-for-sale, Gain (Loss)
AIM IMMUNOTECH INC. (AIM) reported Debt Securities, Available-for-sale, Gain (Loss) of -$915.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleGainLoss · last filed 2022-05-13
- AIM IMMUNOTECH INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2022-03-31 was -$915.00K.
- AIM IMMUNOTECH INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2021-12-31 was $79.00K.
- AIM IMMUNOTECH INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2021-09-30 was -$101.00K, a 234.67% decline year-over-year.
- AIM IMMUNOTECH INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2021-06-30 was -$23.00K.
- AIM IMMUNOTECH INC. debt securities, available-for-sale, gain (loss) for fiscal 2021 was -$47.00K.
| Period end | Debt Securities, Available-for-sale, Gain (Loss) 3 month | Debt Securities, Available-for-sale, Gain (Loss) 6 month | Debt Securities, Available-for-sale, Gain (Loss) 9 month | Debt Securities, Available-for-sale, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$915.00K 10-Q · filed 2022-05-13 | -$836.00K derived: sum of 2 quarters · filed 2022-05-13 | -$937.00K derived: sum of 3 quarters · filed 2022-05-13 | -$960.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$22.00K derived: sum of 2 quarters · filed 2022-03-31 | -$45.00K derived: sum of 3 quarters · filed 2022-03-31 | -$47.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | -$101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$124.00K derived: sum of 2 quarters · filed 2021-11-15 | -$126.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$25.00K 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | -$2.00K 10-Q · filed 2021-05-17 | |||
| 2020-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $12.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$63.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |